Type 1 Diabetes Across the Disease Continuum
Ashlyn Smith, MMS, PA-C, DipACLM, BC-ADM, DFAAPA
In this series, Ashlyn Smith, a PA in endocrinology and founder of ELM Endocrinology & Lifestyle Medicine, PLLC, examines type 1 diabetes across the disease continuum, including common diagnostic myths, risk based screening, disease staging, and stage specific treatment considerations.
PA Smith highlights evidence based approaches to early identification, patient education, referral, and multidisciplinary management to reduce complications such as diabetic ketoacidosis and support improved clinical outcomes.
Video 1: T1D Myths That Delay Diagnosis
Debunk some common myths about T1D held by clinicians and patients, from the typical age of diagnosis to the role of family history.
Video 2: T1D Is a Staged Disease, Not a Sudden Diagnosis
Understand the three stages of T1D, the role that autoantibodies and glucose monitoring play in staging, and how early diagnosis can affect disease progression.
Video 3: T1D Screening to Identify Risk Before Symptoms
Which patients should be screened for T1D, how should they be screened, and what should you do when you receive a positive test? PA Ashlyn Smith explains.
Video 4: T1D Treatment Considerations at Every Stage
This video covers treatment of T1D in stages 1, 2, and 3, including helping patients manage the emotional impact of the diagnosis and the importance of facilitating the engagement of a multidisciplinary care team.
Supported by
